Angela M. Carter

2.6k total citations
36 papers, 1.7k citations indexed

About

Angela M. Carter is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Angela M. Carter has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Epidemiology. Recurrent topics in Angela M. Carter's work include Blood Coagulation and Thrombosis Mechanisms (8 papers), Blood properties and coagulation (7 papers) and Platelet Disorders and Treatments (6 papers). Angela M. Carter is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (8 papers), Blood properties and coagulation (7 papers) and Platelet Disorders and Treatments (6 papers). Angela M. Carter collaborates with scholars based in United Kingdom, United States and Germany. Angela M. Carter's co-authors include Peter J. Grant, Robert A.S. Ariëns, John W. Weisel, Kristina F. Standeven, Andrew J. Catto, John Bamford, Maria Arriero, Evis Harja, Ann Marie Schmidt and Barry I. Hudson and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Circulation.

In The Last Decade

Angela M. Carter

35 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela M. Carter United Kingdom 20 489 412 392 283 276 36 1.7k
Jacob van den Born Netherlands 36 277 0.6× 366 0.9× 888 2.3× 133 0.5× 183 0.7× 119 3.3k
Waichi Sato Japan 30 330 0.7× 139 0.3× 988 2.5× 240 0.8× 204 0.7× 79 2.9k
J. Floege Germany 25 343 0.7× 140 0.3× 533 1.4× 90 0.3× 89 0.3× 68 2.4k
Khurrum Shahzad Germany 23 132 0.3× 390 0.9× 661 1.7× 233 0.8× 84 0.3× 46 1.8k
Tetsu Akimoto Japan 22 331 0.7× 166 0.4× 362 0.9× 139 0.5× 49 0.2× 137 1.8k
Masashi Sakuma Japan 22 442 0.9× 262 0.6× 860 2.2× 342 1.2× 72 0.3× 128 2.9k
Ellen T. McCarthy United States 28 408 0.8× 132 0.3× 574 1.5× 108 0.4× 66 0.2× 60 2.7k
Changli Wei United States 27 493 1.0× 276 0.7× 1.2k 3.2× 170 0.6× 49 0.2× 61 4.2k
Domenico Del Principe Italy 26 188 0.4× 313 0.8× 455 1.2× 141 0.5× 41 0.1× 78 1.7k
Mingjun Shi China 26 379 0.8× 83 0.2× 1.2k 3.0× 522 1.8× 110 0.4× 64 4.1k

Countries citing papers authored by Angela M. Carter

Since Specialization
Citations

This map shows the geographic impact of Angela M. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela M. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela M. Carter more than expected).

Fields of papers citing papers by Angela M. Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela M. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela M. Carter. The network helps show where Angela M. Carter may publish in the future.

Co-authorship network of co-authors of Angela M. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Angela M. Carter. A scholar is included among the top collaborators of Angela M. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela M. Carter. Angela M. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Aguilar, Jenny I., Mary Hongying Cheng, Josep Font, et al.. (2021). Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia. eLife. 10. 15 indexed citations
3.
Cheng, Mary Hongying, et al.. (2021). Bile Acids Gate Dopamine Transporter Mediated Currents. Frontiers in Chemistry. 9. 753990–753990. 7 indexed citations
4.
Si, Yingnan, Seulhee Kim, Yun Lü, et al.. (2020). Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy. Cancer Gene Therapy. 28(7-8). 799–812. 29 indexed citations
5.
Martinez, Jonathan O., Roberto Molinaro, Kelly A. Hartman, et al.. (2018). Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery. Theranostics. 8(4). 1131–1145. 100 indexed citations
6.
Wright, Mark, et al.. (2015). Complement and Cardiovascular Disease - The Missing Link in Haemodialysis Patients?. ˜The œNephron journals/Nephron journals. 132(1). 5–14. 29 indexed citations
7.
Carter, Angela M., Stephen Gutowski, & Paul C. Sternweis. (2014). Regulated Localization Is Sufficient for Hormonal Control of Regulator of G Protein Signaling Homology Rho Guanine Nucleotide Exchange Factors (RH-RhoGEFs). Journal of Biological Chemistry. 289(28). 19737–19746. 10 indexed citations
8.
Carter, Angela M., et al.. (2013). Activated RhoA Is a Positive Feedback Regulator of the Lbc Family of Rho Guanine Nucleotide Exchange Factor Proteins. Journal of Biological Chemistry. 288(16). 11325–11333. 41 indexed citations
9.
Wei, Jung‐Nan, Hung‐Yuan Li, Fung‐Chang Sung, et al.. (2012). Obesity and clustering of cardiovascular disease risk factors are associated with elevated plasma complement C3 in children and adolescents. Pediatric Diabetes. 13(6). 476–483. 14 indexed citations
10.
Willige, Shirley Uitte de, Angela M. Carter, Ton Lisman, et al.. (2011). Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction. Blood. 117(24). 6694–6701. 20 indexed citations
11.
Williams, Frances M. K., Angela M. Carter, Bernet Kato, et al.. (2009). Identification of Quantitative Trait Loci for Fibrin Clot Phenotypes. Arteriosclerosis Thrombosis and Vascular Biology. 29(4). 600–605. 10 indexed citations
12.
Standeven, Kristina F., et al.. (2009). Role of proteomic technologies in understanding risk of arterial thrombosis. Expert Review of Proteomics. 6(5). 539–550. 3 indexed citations
13.
Howes, Joanna‐Marie, Jeff N. Keen, John B. C. Findlay, & Angela M. Carter. (2008). The application of proteomics technology to thrombosis research: the identification of potential therapeutic targets in cardiovascular disease. Diabetes and Vascular Disease Research. 5(3). 205–212. 16 indexed citations
14.
Sternweis, Paul C., et al.. (2007). Regulation of Rho Guanine Nucleotide Exchange Factors by G Proteins. Advances in protein chemistry. 74. 189–228. 44 indexed citations
15.
Standeven, Kristina F., Angela M. Carter, Peter J. Grant, et al.. (2007). Functional analysis of fibrin γ-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness. Blood. 110(3). 902–907. 100 indexed citations
16.
Bray, Paul F., et al.. (2007). β3 integrin haplotype influences gene regulation and plasma von Willebrand factor activity. Atherosclerosis. 198(2). 280–286. 4 indexed citations
17.
Scott, Eleanor, Angela M. Carter, & John B. C. Findlay. (2005). The application of proteomics to diabetes. Diabetes and Vascular Disease Research. 2(2). 54–60. 17 indexed citations
18.
Standeven, Kristina F., et al.. (2003). Functional Analysis of the Fibrinogen Aα Thr312Ala Polymorphism. Circulation. 107(18). 2326–2330. 99 indexed citations
19.
Ariëns, Robert A.S., et al.. (2003). Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. The Lancet. 361(9367). 1424–1431. 149 indexed citations
20.
Catto, Andrew J., et al.. (1997). The Paraoxonase Glutamine/Arginine Polymorphism and Cerebrovascular Disease. Cerebrovascular Diseases. 7(6). 353–355. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacob van den Born Breakdown of academic impact, for papers by Waichi Sato Breakdown of academic impact, for papers by J. Floege Breakdown of academic impact, for papers by Khurrum Shahzad Breakdown of academic impact, for papers by Tetsu Akimoto Breakdown of academic impact, for papers by Masashi Sakuma Breakdown of academic impact, for papers by Ellen T. McCarthy Breakdown of academic impact, for papers by Changli Wei Breakdown of academic impact, for papers by Domenico Del Principe Breakdown of academic impact, for papers by Mingjun Shi
Rankless by CCL
2026